Every 10-Q that Ardent Health, Inc. (ARDT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ARDT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ARDT filings page.
Ardent Health, Inc. reported softer profitability for the quarter ended June 30, 2026. Total revenue was $1.62 billion, down modestly from $1.65 billion a year earlier, but net income attributable to Ardent declined to $16.9 million from $72.9 million, and diluted EPS fell to $0.12 from $0.52.
Results were pressured by a lower contribution from Medicaid supplemental payment programs in the quarter, higher professional fees, self‑insured liability costs and increased general and administrative expenses, including severance and CEO transition costs. For the first six months, revenue rose to $3.22 billion, yet net income attributable to Ardent decreased to $56.7 million. Operating cash flow strengthened to $136.5 million, cash and cash equivalents increased to $724.5 million, and total debt stayed around $1.10 billion, while interest rate swaps moved from a larger net liability to a smaller one, improving other comprehensive income. The company continues to derive most revenue from Texas, Oklahoma and New Mexico, with a payer mix led by Medicare and other managed care.
Ardent Health, Inc. reported Q3 2025 results with total revenue of $1,576,746,000 versus $1,449,817,000 a year ago. A change in accounting estimate reduced revenue by $42.6 million in the quarter after implementing a new revenue accounting system. Net (loss) income attributable to Ardent was $(23,478,000) (basic and diluted EPS $(0.17)), compared with net income of $26,322,000 (EPS $0.19) in Q3 2024.
For the first nine months, revenue reached $4,719,260,000 and net income attributable to Ardent was $90,855,000. Operating cash flow for the nine months was $247,075,000, ending cash was $609,441,000, and total assets were $5,154,373,000. The balance sheet showed long‑term debt (less current) of $1,087,023,000 and equity of $1,633,336,000.
Ardent refinanced its Term Loan B on September 18, 2025, cutting the margin by 50 bps (to Term SOFR + 2.25%) and extending maturity to September 2032. The company acquired 18 urgent care clinics on January 1, 2025 for $27.5 million. As of November 7, 2025, common shares outstanding were 143,187,681.